Naturally occurring NS3-protease-inhibitor resistant mutant A156T in the liver of an untreated chronic hepatitis C patient

被引：62

作者：

Cubero, Maria ^{[1
,2
,3
]}

Esteban, Juan Ignacio ^{[1
,2
,3
]}

Otero, Teresa ^{[1
]}

Sauleda, Silvia ^{[3
,4
]}

Bes, Marta ^{[3
,4
]}

Esteban, Rafael ^{[1
,2
,3
]}

Guardia, Jaurne ^{[1
,2
,3
]}

Quer, Josep ^{[1
,2
,3
]}

机构：

[1] Hosp Univ Vall Hebron, Dept Internal Med, Liver Unit, Barcelona 08035, Spain

[2] Univ Autonoma Barcelona, UAB, Bellaterra, Spain

[3] Inst Salud Carlos III, CIBER Enfermedades Hepat & Digest CIBERRehd, Madrid, Spain

[4] Banc Sang Teixits, Inst Catala Salut, Barcelona, Spain

来源：

VIROLOGY | 2008年 / 370卷 / 02期

关键词：

HCV-NS3; inhibitor; mutant; resistant; untreated; patient;

D O I：

10.1016/j.virol.2007.10.006

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

An increasing number of new hepatitis C virus NS3-protease inhibitors are being evaluated for the treatment of chronic hepatitis C. Treatment-induced selection of mutants conferring resistance to protease inhibitors has been shown both in vivo and in vitro. A specific mutation, A156T has been shown to confer high-level resistance to several such agents (BILN2061, VX-950, SCH446211 (SCH6) and SCH503034). Here we report the presence of the A156T mutation in close to 1% of NS3 sequences within the liver quasispecies of a chronic hepatitis C patient never treated with anti-NS3-protease inhibitors. (c) 2007 Elsevier Inc. All rights reserved.

引用

页码：237 / 245

页数：9

共 36 条

[11] Eigen M., 1988, RNA Genetics, Vol. III, VIII, P211
[12] Multiple molecular pathways for fitness recovery of an RNA virus debilitated by operation of Muller's ratchet
Escarmís, C
Dávila, M
Domingo, E
[J]. JOURNAL OF MOLECULAR BIOLOGY, 1999, 285 (02) : 495 - 505
[13] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
Fried, MW
Shiffman, ML
Reddy, KR
Smith, C
Marinos, G
Goncales, FL
Haussinger, D
Diago, M
Carosi, G
Dhumeaux, D
Craxi, A
Lin, A
Hoffman, J
Yu, J
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) : 975 - 982
[14] RAPID EVOLUTION OF RNA GENOMES
HOLLAND, J
SPINDLER, K
HORODYSKI, F
GRABAU, E
NICHOL, S
VANDEPOL, S
[J]. SCIENCE, 1982, 215 (4540) : 1577 - 1585
[15] HOLLAND JJ, 1992, CURR TOP MICROBIOL, V176, P1
[16] Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers
Kobayashi, S
Ide, T
Sata, M
[J]. JOURNAL OF HEPATOLOGY, 2001, 34 (04) : 584 - 586
[17] Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′ nontranslated region are essential for virus replication in vivo
Kolykhalov, AA
Mihalik, K
Feinstone, SM
Rice, CM
[J]. JOURNAL OF VIROLOGY, 2000, 74 (04) : 2046 - 2051
[18] Prevalence of antiviral drug resistance in untreated patients with cytomegalovirus retinitis
Liu, WQ
Shum, C
Martin, DF
Kuppermann, BD
Hall, AJH
Margolis, TP
[J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (04) : 1234 - 1238
[19] Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitro
Lu, LJ
Pilot-Matias, TJ
Stewart, KD
Randolph, JT
Pithawalla, R
He, WP
Huang, PP
Klein, LL
Mo, HM
Molla, A
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) : 2260 - 2266
[20] Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
Manns, MP
McHutchison, JG
Gordon, SC
Rustgi, VK
Shiffman, M
Reindollar, R
Goodman, ZD
Koury, K
Ling, MH
Albrecht, JK
[J]. LANCET, 2001, 358 (9286) : 958 - 965

← 1 2 3 4 →